Ionis Pharmaceuticals Inc

Connor, Clark & Lunn Investment Management Ltd. IONS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

1,076,370

Value ($000)

85,152

Weight

0.2%

2021 Q1 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	85,152	0.2%	1,076,370	12/31/2025
2025 Q3	11/13/2025	57,449	0.2%	878,155	9/30/2025
2025 Q2	8/7/2025	10,501	0.0%	265,793	6/30/2025
2025 Q1	5/12/2025	3,900	0.0%	129,273	3/31/2025
2024 Q4	2/10/2025	4,384	0.0%	125,389	12/31/2024
2024 Q3	11/8/2024	711	0.0%	17,741	9/30/2024
2024 Q2	8/9/2024	2,109	0.0%	44,256	6/30/2024
2023 Q4	2/9/2024	6,473	0.0%	127,954	12/31/2023
2023 Q3	11/13/2023	5,888	0.0%	129,812	9/30/2023
2023 Q2	8/10/2023	8,145	0.0%	198,508	6/30/2023
2023 Q1	5/10/2023	9,963	0.1%	278,758	3/31/2023
2022 Q4	2/10/2023	8,709	0.1%	230,577	12/31/2022
2022 Q3	11/10/2022	10,131	0.1%	229,061	9/30/2022
2022 Q2	8/5/2022	4,886	0.0%	131,983	6/30/2022
2022 Q1	5/12/2022	5,822	0.0%	157,193	3/31/2022
2021 Q4	2/10/2022	3,424	0.0%	112,525	12/31/2021
2021 Q3	11/12/2021	1,192	0.0%	35,536	9/30/2021
2021 Q1	5/13/2021	2,319	0.0%	51,579	3/31/2021